- Home
- ZCMD vs RADX Comparison
ZCMD vs RADX Comparison
Compare ZCMD & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- RADX
- Stock Information
- Founded
- ZCMD 2012
- RADX 2021
- Country
- ZCMD China
- RADX Australia
- Employees
- ZCMD N/A
- RADX N/A
- Industry
- ZCMD Other Consumer Services
- RADX
- Sector
- ZCMD Real Estate
- RADX
- Exchange
- ZCMD Nasdaq
- RADX NYSE
- Market Cap
- ZCMD 30.3M
- RADX 31.8M
- IPO Year
- ZCMD 2020
- RADX N/A
- Fundamental
- Price
- ZCMD $1.08
- RADX $4.05
- Analyst Decision
- ZCMD
- RADX Strong Buy
- Analyst Count
- ZCMD 0
- RADX 1
- Target Price
- ZCMD N/A
- RADX $15.00
- AVG Volume (30 Days)
- ZCMD 3.8K
- RADX 37.7K
- Earning Date
- ZCMD 01-01-0001
- RADX 02-26-2025
- Dividend Yield
- ZCMD N/A
- RADX N/A
- EPS Growth
- ZCMD N/A
- RADX N/A
- EPS
- ZCMD N/A
- RADX N/A
- Revenue
- ZCMD $17,406,104.00
- RADX $204,609.00
- Revenue This Year
- ZCMD N/A
- RADX N/A
- Revenue Next Year
- ZCMD N/A
- RADX N/A
- P/E Ratio
- ZCMD N/A
- RADX N/A
- Revenue Growth
- ZCMD 1.01
- RADX N/A
- 52 Week Low
- ZCMD $1.00
- RADX $3.50
- 52 Week High
- ZCMD $2.97
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- ZCMD 31.22
- RADX N/A
- Support Level
- ZCMD $1.10
- RADX N/A
- Resistance Level
- ZCMD $1.28
- RADX N/A
- Average True Range (ATR)
- ZCMD 0.08
- RADX 0.00
- MACD
- ZCMD -0.02
- RADX 0.00
- Stochastic Oscillator
- ZCMD 0.00
- RADX 0.00
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.